Current Value of Holding

$0

Shares

0

% of Portfolio

0.00%

Average Buy Price

$11.6

Avg closing price
Price range

2 Joel Greenblatt Aerie Pharmaceuticals Trades

Joel Greenblatt started to build up the position in Aerie Pharmaceuticals in Q3 2022. Since then they sold 11.1 Thousand shares. The investor sold all their shares in Q4 2022 and doesn't own any shares in Aerie Pharmaceuticals anymore.

Avg closing price
Price range
Sold -11.1 Thousand shares Q4 2022
Avg closing price $15.21
Price range $15.10 - $15.25
New holding (+11.1 Thousand shares) Q3 2022
Avg closing price $11.62
Price range $6.37 - $15.23

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!